JPS5855422A - ナルブフイン−麻薬性鎮痛剤組成物 - Google Patents

ナルブフイン−麻薬性鎮痛剤組成物

Info

Publication number
JPS5855422A
JPS5855422A JP57154739A JP15473982A JPS5855422A JP S5855422 A JPS5855422 A JP S5855422A JP 57154739 A JP57154739 A JP 57154739A JP 15473982 A JP15473982 A JP 15473982A JP S5855422 A JPS5855422 A JP S5855422A
Authority
JP
Japan
Prior art keywords
analgesic
pharmaceutically suitable
suitable salt
salt
morphine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP57154739A
Other languages
English (en)
Japanese (ja)
Inventor
マイクル・リチヤ−ド・マドル−ダ−
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAIKURU RICHIYAADO MAGURUUDAA
Original Assignee
MAIKURU RICHIYAADO MAGURUUDAA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAIKURU RICHIYAADO MAGURUUDAA filed Critical MAIKURU RICHIYAADO MAGURUUDAA
Publication of JPS5855422A publication Critical patent/JPS5855422A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP57154739A 1981-09-08 1982-09-07 ナルブフイン−麻薬性鎮痛剤組成物 Pending JPS5855422A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US300394 1981-09-08
US06/300,394 US4366159A (en) 1981-09-08 1981-09-08 Nalbuphine-narcotic analgesic composition and method of producing analgesia

Publications (1)

Publication Number Publication Date
JPS5855422A true JPS5855422A (ja) 1983-04-01

Family

ID=23158917

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57154739A Pending JPS5855422A (ja) 1981-09-08 1982-09-07 ナルブフイン−麻薬性鎮痛剤組成物

Country Status (14)

Country Link
US (1) US4366159A (enExample)
EP (1) EP0074105A1 (enExample)
JP (1) JPS5855422A (enExample)
AR (1) AR228984A1 (enExample)
AU (1) AU549070B2 (enExample)
CA (1) CA1200501A (enExample)
FI (1) FI823112A7 (enExample)
GR (1) GR76702B (enExample)
HU (1) HU190699B (enExample)
IL (1) IL66743A (enExample)
NZ (1) NZ201841A (enExample)
PH (1) PH18772A (enExample)
PT (1) PT75521A (enExample)
ZA (1) ZA826500B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006151990A (ja) * 1993-10-07 2006-06-15 Euro Celtique Sa 持効性経口投与オピオイド製剤

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4477457A (en) * 1982-10-28 1984-10-16 E. I. Du Pont De Nemours And Company Method for inducing anorexia using nalmetrene
US4478840A (en) * 1983-10-11 1984-10-23 E. I. Du Pont De Nemours And Company Appetite suppressing compositions and methods
US4885173A (en) * 1985-05-01 1989-12-05 University Of Utah Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities
US4769372A (en) * 1986-06-18 1988-09-06 The Rockefeller University Method of treating patients suffering from chronic pain or chronic cough
GB8820327D0 (en) * 1988-08-26 1988-09-28 May & Baker Ltd New compositions of matter
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
WO2003004033A1 (en) 2001-07-06 2003-01-16 Penwest Pharmaceuticals Company Sustained release formulations of oxymorphone
WO2003004030A1 (en) * 2001-07-06 2003-01-16 Endo Pharmaceuticals, Inc. Oxymorphone controlled release formulations
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US20140271788A1 (en) 2013-03-15 2014-09-18 Monosol Rx, Llc Sublingual and buccal film compositions
PT2939696E (pt) 2001-10-18 2016-06-17 Nektar Therapeutics Conjugados poliméricos de antagonistas de opióides
EP2422773A3 (en) 2002-09-20 2012-04-18 Alpharma, Inc. Sequestering subunit and related compositions and methods
US7192966B2 (en) * 2002-11-15 2007-03-20 Branded Products For The Future Pharmaceutical composition
AU2003296954A1 (en) * 2002-12-13 2004-07-09 The Regents Of The University Of California Analgesic combination comprising nalbuphine
RS53279B (sr) * 2003-12-16 2014-08-29 Nektar Therapeutics Monodisperzne smeše pegilisanog naloksola
US20060182692A1 (en) * 2003-12-16 2006-08-17 Fishburn C S Chemically modified small molecules
ES2636657T3 (es) 2006-06-19 2017-10-06 Alpharma Pharmaceuticals Llc Composición farmacéutica
US20080318994A1 (en) 2007-06-21 2008-12-25 Endo Pharmaceuticals, Inc. Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
US20080318993A1 (en) * 2007-06-21 2008-12-25 Endo Pharmaceuticals, Inc. Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Hepatic Impairment
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
FR2963889B1 (fr) * 2010-08-20 2013-04-12 Debregeas Et Associes Pharma Formulations a base de nalbuphine et leurs utilisations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB769517A (en) * 1953-10-20 1957-03-06 Merck & Co Inc Analgesic compositions
US3493657A (en) * 1961-03-14 1970-02-03 Mozes Juda Lewenstein Therapeutic compositions of n-allyl-14-hydroxy - dihydronormorphinane and morphine
IL26896A (en) * 1966-01-19 1970-11-30 Endo Lab 14 - Hydroxynormorphinins and 14 - Hydroxynormorphinones
US3773955A (en) * 1970-08-03 1973-11-20 Bristol Myers Co Analgetic compositions
US3879555A (en) * 1970-11-16 1975-04-22 Bristol Myers Co Method of treating drug addicts
GB1390772A (en) * 1971-05-07 1975-04-16 Endo Lab Oral narcotic composition
US3966940A (en) * 1973-11-09 1976-06-29 Bristol-Myers Company Analgetic compositions
US4237140A (en) * 1979-05-18 1980-12-02 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and acetaminophen
US4282215A (en) * 1980-06-17 1981-08-04 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and acetylsalicylic acid, derivative or salt thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006151990A (ja) * 1993-10-07 2006-06-15 Euro Celtique Sa 持効性経口投与オピオイド製剤

Also Published As

Publication number Publication date
AR228984A1 (es) 1983-05-13
AU8804282A (en) 1983-03-17
PT75521A (en) 1982-10-01
US4366159A (en) 1982-12-28
PH18772A (en) 1985-09-25
IL66743A0 (en) 1982-12-31
FI823112L (fi) 1983-03-09
EP0074105A1 (en) 1983-03-16
IL66743A (en) 1986-07-31
AU549070B2 (en) 1986-01-09
HU190699B (en) 1986-10-28
ZA826500B (en) 1984-04-25
GR76702B (enExample) 1984-08-29
FI823112A0 (fi) 1982-09-08
NZ201841A (en) 1984-12-14
CA1200501A (en) 1986-02-11
FI823112A7 (fi) 1983-03-09

Similar Documents

Publication Publication Date Title
JPS5855422A (ja) ナルブフイン−麻薬性鎮痛剤組成物
TWI451868B (zh) 醫藥組成物之改良及相關之改良
RU2541159C2 (ru) Композиции и способы для смягчения дыхательной недостаточности, вызванной передозировкой опиоидов
Edwards et al. Clinical pharmacokinetics of pethidine: 1982
RU2552786C2 (ru) Жидкий назальный спрей, содержащий налтрексон в низкой дозе
JPH0144684B2 (enExample)
CN101622013A (zh) 包含丁丙诺啡和纳洛酮的改善的药用组合物
JP2009280602A (ja) 門脈圧亢進症の予防及び／又は治療
US8497280B2 (en) Medicinal compositions comprising buprenorphine and nalmefene
AU689577B2 (en) New combination of a beta -receptor blocker and a local anaesthetic
JPH06507152A (ja) グラニセトロンおよびデキサメタゾン含有の医薬組成物
AU2011254554B2 (en) Liquid nasal spray containing low-dose naltrexone
AU2014201777A1 (en) Improvements in and relating to medicinal compositions
AU2017213491A1 (en) Formulations and methods for attenuating respiratory depression induced by opioid overdose
AU2014201782A1 (en) Improved medicinal compositions comprising buprenorphine and naltrexone